跳至主要内容
临床试验/JPRN-UMIN000016541
JPRN-UMIN000016541已完成3 期

The efficacy of ramelteon, selective melatonin receptor agonist, during the critical care: MELIt Trial (Melatonin Evaluation of Lowered Inflammation in ICU Trial) - MELIt Trial

The emergency and critical care department, Nagoya university hospital.0 个研究点目标入组 88 人开始时间: 2015年3月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
88

研究概览

简要总结

As the primary endpoint, there was a trend toward decrease in the duration of ICU stay (4.56 d) in the ramelteon group compared with the placebo group (5.86 d) (p = 0.082 and p = 0.028 before and after adjustments).

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria is the patient who is contraindicated for ramelteon, who is not receiving ramelteon therapy, who is admitted to our ICU during at least 2 days.

研究者

发起方
The emergency and critical care department, Nagoya university hospital.

相似试验